Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride works better for hair loss in patients 26 or younger.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Lespedeza cuneata extract may help treat enlarged prostate.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride effectively reduces symptoms of enlarged prostate with minimal side effects.

Dutasteride reduces DHT more effectively than finasteride.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Finasteride reduces prostate size and symptoms with few side effects.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Early hair loss may indicate future prostate issues.

Finasteride treats hair loss but may affect prostate cancer detection.

The healthcare for transgender veterans could be better with a more unified team approach.